ClinVar Miner

Submissions for variant NM_004380.3(CREBBP):c.3779+1G>C

dbSNP: rs587783483
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
New York Genome Center RCV001252207 SCV001622848 likely pathogenic Rubinstein-Taybi syndrome due to CREBBP mutations 2020-06-12 criteria provided, single submitter clinical testing The c.3779+1G>C canonical splice site variant identified in the CREBBP gene has not been reported in the literature. A de novo allelic variant c.3779+1G>A has been reported in anindividual with intellectual disability, short stature, dysmorphic features, but no broad thumbs or great toes as usually seen in Rubinstein-Taybi syndrome [PMID: 27165009] and another de novo allelic variant c.3779+1G>T has been reported in an individual with classical Rubinstein-Taybi syndrome phenotype [PMID: 29132461]. The c.3779+1G>C splice site variant is not reported in gnomAD database indicating this is a rare allele and predicted to damage the canonical splice donor site in intron 20, leads to skipping of exon 20 resulting in-frame deletion of 81 bp in the CREBBP gene [PMID: 27165009]. At the protein level, the deletion of 27 amino acids partially deletes the DUF902 domain which is localized in the histone acetyltransferase (HAT) domain. As most missense mutations found in Rubinstein-Taybi syndrome are clustered in the HAT domain, it was suggested that loss of HAT activity may be sufficient to cause Rubinstein-Taybi syndrome [PMID: 27165009]. Based on the available evidence, the variant c.3779+1G>C in the CREBBP gene is classified as likely pathogenic.
Centre de Biologie Pathologie Génétique, Centre Hospitalier Universitaire de Lille RCV001252207 SCV001427958 pathogenic Rubinstein-Taybi syndrome due to CREBBP mutations 2019-01-01 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.